Kestra Medical Technologies, Ltd. (NYSE: KMTS) has been gaining attention in the healthcare sector, particularly among investors keen on the medical instruments and supplies industry. The company, with its focus..
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) is generating significant buzz in the healthcare sector with an enticing potential upside of 24.62%, according to recent analyst ratings. This UK-based biopharmaceutical company,..
Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising drug pipeline and a staggering potential upside of 184.86%. Based in San Diego,..
Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector focusing on medical devices, has caught the attention of investors with its promising growth potential. Based in Lansing, Michigan,..
Premier, Inc. (NASDAQ: PINC), a key player in the Health Information Services industry, stands at the intersection of healthcare innovation and financial stability. With a market capitalization of $2.34 billion,..
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company dedicated to developing and commercializing treatments for central nervous system (CNS) diseases, presents an intriguing opportunity for investors. With a market capitalization..
AdaptHealth Corp. (NASDAQ: AHCO) is a company that has captured the attention of investors with its solid footing in the healthcare sector, specifically within the medical devices industry. As a..
PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, stands out with a market capitalization of $5.5 billion. Headquartered in Warren, New Jersey, the company focuses on..
Agios Pharmaceuticals, Inc. (AGIO), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising growth potential. Headquartered in Cambridge, Massachusetts, Agios focuses on discovering..
Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a burgeoning player in the biotechnology space, is capturing the attention of investors with a compelling growth narrative. With a market capitalization of $5.4 billion,..
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents a compelling opportunity for investors, particularly those focused on the healthcare sector. Operating within the niche of Drug Manufacturers – Specialty & Generic, ANI..
Investors eyeing the healthcare sector may find Dynavax Technologies Corporation (NASDAQ: DVAX) an intriguing prospect. As a commercial-stage biopharmaceutical company with a focus on vaccine development, Dynavax has positioned itself..
National HealthCare Corporation (NYSE: NHC) is a notable entity within the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $2.51 billion, NHC operates a..
Investors eyeing opportunities in the healthcare sector may find CONMED Corporation (NASDAQ: CNMD) an intriguing prospect, especially given its potential upside of 20.67% according to recent analyst ratings. As a..
For investors seeking exposure in the healthcare sector, GRAIL, Inc. (NASDAQ: GRAL) presents an intriguing opportunity. With a market capitalization of $2.02 billion, GRAIL operates in the diagnostics and research..
Immunocore Holdings plc (NASDAQ: IMCR) is making waves in the biotechnology sector, capturing the attention of investors with its innovative approach to immunomodulating medicines and a striking potential upside of..
Disc Medicine, Inc. (NASDAQ: IRON) is capturing significant attention within the biotechnology sector, not only for its innovative approach to addressing serious hematologic diseases but also for its compelling investment..
Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specifically within the medical care facilities industry, offers a compelling investment opportunity with a potential upside of..
Travere Therapeutics, Inc. (NASDAQ: TVTX) is making waves in the biopharmaceutical sector with its innovative approach to treating rare kidney and metabolic diseases. With a market capitalization of $2.56 billion,..
Phreesia, Inc. (NYSE: PHR), a prominent player in the health information services industry, is capturing investor attention with a remarkable potential upside of 137.73%. This intriguing figure stems from the..
